Teva and Viatris revives chance to dispute J&J’s schizophrenia drug patent (NYSE:TEVA)
Teva Pharmaceuticals (NYSE:TEVA) and Viatris (NASDAQ:VTRS) have reportedly won a new chance to challenge patent covering Johnson and Johnson's (NYSE:JNJ) ...
Thursday, December 5, 2024
Tag: JJs
Amgen settles patent lawsuit over biosimilar of J&J’s big-selling Stelara By Reuters
© Reuters. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California October 21, ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.